This is a summary of the European public assessment report (EPAR) for Insulatard. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Insulatard.
Therapeutic Indication
Treatment of diabetes mellitus.
Therapeutic Area (MeSH)
ATC Code
A10AC01
ATC Item
N/A
Pharmacotherapeutic Group
Drugs used in diabetes
Active Substance (Summary)
INN / Common Names
EMA Name
Insulatard
Medicine Name
Insulatard
Aliases
N/ANo risk management plan link.
